Abstract:Lipid nanoparticles (LNPs) are a type of lipid vesicles that possess a homogeneous lipid core. These vesicles are widely used in small-molecule drug and nucleic acid delivery and recently gained much attention because of their remarkable success as a delivery platform for COVID-19 mRNA vaccines. Nonetheless, the utility of transient protein expression induced by mRNA extends far beyond vaccines against infectious diseases─they also hold promise as cancer vaccines, protein replacement therapies, and gene editing components for rare genetic diseases. However, naked mRNA is inherently unstable and prone to rapid degradation by nucleases and self-hydrolysis. Encapsulation of mRNA within LNPs protects mRNA from extracellular ribonucleases and assists with intracellular mRNA delivery.In this Account, we discuss the core features of LNPs for RNA delivery. We focus our attention on LNPs designed to deliver mRNA; however, we also include examples of siRNA-LNP delivery where appropriate to highlight the commonalities and the dissimilarities due to the nucleic acid structure. First, we introduce the concept of LNPs, the advantages and disadvantages of utilizing nucleic acids as therapeutic agents, and the general reasoning behind the molecular makeup of LNPs. We also briefly highlight the most recent clinical successes of LNP-based nucleic acid therapies. Second, we describe the theory and methods of LNP self-assembly. The common idea behind all of the preparation methods is inducing electrostatic interactions between the nucleic acid and charged lipids and promoting nanoparticle growth via hydrophobic interactions. Third, we break down the LNP composition with special attention to the fundamental properties and purposes of each component. This includes the identified molecular design criteria, commercial sourcing, impact on intracellular trafficking, and contribution to the properties of LNPs. One of the key components of LNPs is ionizable lipids, which initiate electrostatic binding with endosomal membranes and facilitate cytosolic release; however, the roles of other lipid components should not be disregarded, as they are associated with stability, clearance, and distribution of LNPs. Fourth, we review the attributes of LNP constructs as a whole that can heavily influence RNA delivery. These attributes are LNP size, charge, internal structure, lipid packing, lipid membrane hydration, stability, and affinity toward biomacromolecules. We also discuss the specific techniques used to examine these attributes and how they can be adjusted. Finally, we offer our perspective on the future of RNA therapies and some questions that remain in the realm of LNP formulation and optimization.

A Facile Method to Prepare Non-Cationic Mrna Lipid-Nanoparticles Based on Frame Guided Assembly Strategy

Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA

A cationic lipid with advanced membrane fusion performance for pDNA and mRNA delivery

Dual Ethanolamine Head Groups in Ionizable Lipids Facilitate Phospholipid-free Stable Nanoparticle Formulation for Augmented and Safer mRNA Delivery

A Fluorinated Ionizable Lipid Improves the Mrna Delivery Efficiency of Lipid Nanoparticles

A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing

Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver

A Multidimensional Approach to Modulating Ionizable Lipids for High-Performing and Organ-Selective mRNA Delivery.

Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo

Zwitterionic Polymer-Functionalized Lipid Nanoparticles for the Nebulized Delivery of mRNA

Chemistry of Lipid Nanoparticles for RNA Delivery

Lipid Polymer Hybrid Nanomaterials for mRNA Delivery

High-throughput synthesis and optimization of ionizable lipids through A3 coupling for efficient mRNA delivery

Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics

Recent Advances in Lipid Nanoparticles for Delivery of mRNA

Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA

Ionizable Lipids from Click Reactions for Lipid Nanoparticle Assembling and Mrna Delivery

Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery

A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery

Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery